Subsequently, the released plasma glucagon levels induce β-oxidation, which stimulates fatty acid oxidation instead of carbohydrate oxidation reducing the liver triglyceride content and producing improvement of hepatic steatosis [14]. Here, GCG is linked to fatty liver disease.